The Serum ionized calcium , thrombin time (TT), fibrinogen (FIB) after Heparin and Sodium Citrate Anticoagulation in Children with Sepsis

serum iCa2+ , thrombin time (TT), fibrinogen (FIB)

  • Huixia Wang 1Department of Peditric Emergency and Intensive Care Unit, Northwest Women’s and Children’s Hospital, Xi’an 710061, Shaanxi Province, China
Keywords: serum iCa2 , thrombin time (TT), fibrinogen (FIB),heparin anticoagulation; sodium citrate anticoagulation; children with sepsis; continuous blood purification; anticoagulation risk; bleeding risk,

Abstract


Introduction: it aimed to compare the anticoagulant effect and bleeding risk of systemic heparin anticoagulation and local sodium citrate anticoagulation in continuous renal replacement therapy(CRRT) in children with sepsis in the intensive care unit (ICU).

Method: the clinical data of 96 children with sepsis in ICU treated in Northwest Women’s and Children’s Hospitalfrom January 2021 to January 2024 were retrospectively analyzed. The children were divided into control group (CG) and observation group (OG). The coagulation function indexes, blood purification treatment effect, and the incidence of bleeding events during CRRT were compared.

Result: after treatment, activated partial thromboplastin time (APTT), prothrombin time (PT), and thrombin time (TT) were visibly increased, while fibrinogen (FIB) was visibly decreased; APTT, PT, and TT increased visibly, and FIB decreased visibly in the OG;the results of pH, HCO3-, Na+ were visibly different from those before treatment; creatinine (Cr) and urea nitrogen (BUN) were visibly lower, and the decrease of Cr and BUN in the OG was slightly higher as against the CG; the iCa2+ was visibly higher in the OG as against the CG; the incidence of bleeding in the OG was 27.08%, which was visibly lower than 35.42% in the CG (all P < 0.05).

Conclusion: local sodium citrate anticoagulation shows a good anticoagulation effect in CRRT in children with sepsis in ICU, and the bleeding risk is relatively low.

References

Baaten, C.C.F.M.J., Sternkopf, M., Henning, T., Marx, N., Jankowski, J. and Noels, H., 2021. Platelet function in ckd: a systematic review and meta-analysis. J. Am. Soc. Nephrol., 32(7): 1583-1598. https://doi.org/10.1681/asn.2020101440
Califano, A.M., Bitker, L., Baldwin, I., Fealy, N. and Bellomo, R., 2020. Circuit survival during continuous venovenous hemodialysis versus continuous venovenous hemofiltration. Blood Purif., 49(3): 281-288. https://doi.org/10.1159/000504037
De Smet, K., Claus, P.E., Alliet, G., Simpelaere, A. and Desmet, G., 2019. Lemierre’s syndrome: a case study with a short review of literature. Acta Clin. Belg., 74(3): 206-210. https://doi.org/10.1080/17843286.2018.1474614
Hellman, T., Uusalo, P. and Järvisalo, M.J., 2021. Continuous hemodialysis with citrate anticoagulation and standard dialysate for managing acute kidney injury in patients with moderate to severe hyponatremia-A retrospective study. Acta Anaesthesiol. Scand., 65(6): 778-784. https://doi.org/10.1111/aas.13798
Hopp, M.T. and Imhof, D., 2021. Linking labile heme with thrombosis. J. Clin. Med., 10(3): 427. https://doi.org/10.3390/jcm10030427
Jawale, C.V., Li, D.D., Ramani, K., Lin, L., Li, K., Methe, B. and Biswas, P.S., 2021. Uremia coupled with mucosal damage predisposes mice with kidney disease to systemic infection by commensal candida albicans. Immunohorizons, 5(1): 16-24. https://doi.org/10.4049/immunohorizons.2000114
Komatsu, N., Arita, K., Mitsui, H., Nemoto, T. and Hanaki, K., 2021. Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study. Int. J. Hematol., 114(1): 8-17. https://doi.org/10.1007/s12185-021-03123-9
Lazem, M., Sheikhtaheri, A. and Hooman, N., 2021. Lessons learned from hemolytic uremic syndrome registries: recommendations for implementation. Orphanet. J. Rare Dis., 16(1): 240. https://doi.org/10.1186/s13023-021-01871-9
Li, L., Bai, M., Zhang, W., Zhao, L., Yu, Y. and Sun, S., 2022. Regional citrate anticoagulation versus low molecular weight heparin for CRRT in hyperlactatemia patients: a retrospective case-control study. Int. J. Artif. Organs., 45(4): 343-350. https://doi.org/10.1177/03913988211003586
Li, R., Xiao, C., Liu, H., Huang, Y., Dilger, J.P. and Lin, J., 2018. Effects of local anesthetics on breast cancer cell viability and migration. BMC Cancer, 18(1): 666. https://doi.org/10.1186/s12885-018-4576-2
Liang, S., Guan, M., Liu, Z., Ruan, X., Huang, H. and Zhong, H., 2023. Sailing between scylla and charybdis-anticoagulation dilemma in a patient with calciphylaxis and mechanical cardiac valve replacement: a case report and literature review. Ren. Fail., 45(2): 2264401. https://doi.org/10.1080/0886022x.2023.2264401
Lim, C.C., Tan, H.Z., Tan, C.S., Healy, H., Choo, J. and Franca Gois, P.H., 2021. Desmopressin acetate to prevent bleeding in percutaneous kidney biopsy: a systematic review. Intern. Med. J., 51(4): 571-579. https://doi.org/10.1111/imj.14774
Loughrey, P.B., Baker, G., Herron, B., Cooke, S., Iacovazzo, D., Lindsay, J.R. and Korbonits, M., 2021. Invasive ACTH-producing pituitary gland neoplasm secondary to MSH2 mutation. Cancer Genet., 256-257: 36-39. https://doi.org/10.1016/j.cancergen.2021.03.008
Ma, J.C., Gong, B.C. and Zhao, Q., 2023. Pan-cancer analysis of cuproptosis-promoting gene signature from multiple perspectives. Clin. Exp. Med., 23(8): 4997-5014. https://doi.org/10.1007/s10238-023-01108-y
Monardo, P., Lacquaniti, A., Campo, S., Bucca, M., Casuscelli di Tocco, T., Rovito, S., Ragusa, A. and Santoro, A., 2021. Updates on hemodialysis techniques with a common denominator: The personalization of the dialytic therapy. Semin. Dial, 34(3): 183-195. https://doi.org/10.1111/sdi.12956
Moura, E.I.M., de Brito, G.A., Alves, J.A., Imanishe, M.H., Baptista, A.L., Andrade, L.A.S. and Pereira, B.J., 2021. Efficacy and safety of regional anticoagulation with 4% trisodium citrate versus heparin in extended hemodialysis among critical patients with cancer and acute kidney injury. Blood Purif., 50(1): 50-56. https://doi.org/10.1159/000507874
Panpetch, W., Kullapanich, C., Dang, C.P., Visitchanakun, P., Saisorn, W., Wongphoom, J., Wannigama, D.L., Thim-Uam, A., Patarakul, K., Somboonna, N., Tumwasorn, S. and Leelahavanichkul, A., 2021. Candida administration worsens uremia-induced gut leakage in bilateral nephrectomy mice, an impact of gut fungi and organismal molecules in uremia. Msystems;6(1):e01187-20. https://doi.org/10.1128/msystems.01187-20
Reis, D.C.M.V., Alvarenga, L., Cardozo, L.F.M.F., Baptista, B.G., Fanton, S., Paiva, B.R., Ribeiro-Alves, M., Fortunato, R.S., Vasconcelos, A.L., Nakao, L.S., Sanz, C.L., Berretta, A.A., Leite, M. Jr and Mafra, D., 2024. Can curcumin supplementation break the vicious cycle of inflammation, oxidative stress, and uremia in patients undergoing peritoneal dialysis? Clin. Nutr. ESPEN, 59: 96-106. https://doi.org/10.1016/j.clnesp.2023.11.015
Swami, N., Hwang, W.L., Guo, J.A., Hoffman, H., Abramowitz, M.C., Elbakouny, Z., Beltran, H., Chipidza, F., Choueiri, T., Pra, A.D., Huang, F., Kaochar, S., Kantoff, P., Kim, D.W., Kishan, A.U., Kobetz, E., Marinac, C., Mucci, L.A., Muralidhar, V., Pollack, A., Sanford, N.N., Schaeffer, E.M., Spratt, D.E., Zhao, S.G., Rebbeck, T.R., Nguyen, P.L., Feng, F.Y., Mahal, B.A. and Alshalalfa, M., 2021. Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE). Cancer Genet., 258-259:61-68. https://doi.org/10.1016/j.cancergen.2021.08.004
Tantisattamo, E. and Kalantar-Zadeh, K., 2021. Editorial: novel therapeutic approaches in chronic kidney disease, uremia and kidney transplantation: past, present and future. Curr. Opin. Nephrol. Hypertens., 30(1): 1-4. https://doi.org/ 10.1097/MNH.0000000000000575
Tsai, H.H.C., Moyers, J.T., Moore, C.J. and Thinn, M., 2021. Activated prothrombin complex concentrate-induced atypical hemolytic uremic syndrome treated with eculizumab. Am. J. Case Rep., 22: e929616. https://doi.org/10.12659/ajcr.929616
Whitcroft, K.L., Gunder, N., Cuevas, M., Andrews, P., Menzel, S., Haehner, A. and Hummel, T., 2021. Intranasal sodium citrate in quantitative and qualitative olfactory dysfunction: results from a prospective, controlled trial of prolonged use in 60 patients. Eur. Arch. Otorhinolaryngol., 278(8): 2891-2897. https://doi.org/10.1007/s00405-020-06567-7
Xiang, H., Song, B., Zhang, Y., Zhang, J. and Xiong, J., 2021. The effectiveness of continuous renal replacement therapy in critical COVID-19 patients with cytokine release syndrome: a retrospective, multicenter, descriptive study from Wuhan, China. Aging (Albany NY), 13(7): 9243-9252. https://doi.org/10.18632/aging.202838
Xue, W., Cheng, J., Zhao, J., Wang, L., Peng, A. and Liu, X., 2023. Comparison potassium sodium hydrogen citrate with sodium bicarbonate in urine alkalization: a prospective crossover-controlled trial. Int. Urol. Nephrol., 55(1): 61-68. https://doi.org/10.1007/s11255-022-03387-y
Yu, M.L. and Kao, J.H., 2021. Reply to “Tacrolimus concentrations were not affected by glecaprevir/pibrentasvir treatment for hepatitis C virus infection in an adult living donor liver transplant recipient with uremia”. J. Formos. Med. Assoc., 120(6): 1410-1411. https://doi.org/10.1016/j.jfma.2020.12.023
Zhang, W., Bai, M., Zhang, L., Yu, Y., Li, Y., Zhao, L., Yue, Y., Li, Y., Zhang, M., Fu, P., Sun, S. and Chen, X., 2022. Development and external validation of a model for predicting sufficient filter lifespan in anticoagulation-free continuous renal replacement therapy patients. Blood Purif., 51(8): 668-678. https://doi.org/10.1159/000519409
Zhao, B., Ni, Y. and Tian, X., 2019. Low plasma cholinesterase activity is associated with postoperative delirium after noncardiac surgery in elderly patients: aprospective observational study. Psychosomatics, 60(2): 190-196. https://doi.org/10.1016/j.psym.2018.06.014
Zhao, L., Ma, F., Yu, Y., Li, Y., Wang, Y., He, L., Zhou, M., Tian, X., Jing, R., Li, L., Li, L., Huang, C., Bai, M. and Sun, S., 2020. Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in acute severe hypernatremia patients with increased bleeding risk: a retrospective cohort study. Blood Purif., 49(1-2): 44-54. https://doi.org/10.1159/000502937
Published
2025/04/09
Section
Original paper